cell therapy

Cell & Gene Therapy Space Gears Up for First CRISPR Approval
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
BioSpace
CRISPR
gene therapy
cell therapy
sickle cell disease
exa-cel
Vertex Pharmaceuticals
CRISPR Therapeutics
Flag link:
Bayer adds a new life science incubator in China
Bayer adds a new life science incubator in China
Pharmaphorum
Bayer
Co.Lab
incubators
China
oncology
cell therapy
gene therapy
Flag link:
AstraZeneca Drops $245M on Cell and Gene Therapies in Deal with Cellectis
AstraZeneca Drops $245M on Cell and Gene Therapies in Deal with Cellectis
BioSpace
AstraZeneca
Cellectis
cell therapy
gene therapy
Flag link:
ThermoGenesis opens cell and gene therapy facility in Sacramento, US
ThermoGenesis opens cell and gene therapy facility in Sacramento, US
Pharmaceutical Business Review
Thermogenesis
cell therapy
gene therapy
California
Flag link:
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
Fierce Pharma
JNJ
Legend Biotech
Multiple Myeloma
CAR-T
Carvykti
cell therapy
Flag link:
Athersys inches closer to bankruptcy as stroke cell therapy fails interim analysis
Athersys inches closer to bankruptcy as stroke cell therapy fails interim analysis
Fierce Biotech
Athersys
stroke
ischemic stroke
MultiStem
cell therapy
Flag link:
Bayer christens $250M cell therapy 'launch facility' in Berkeley
Bayer christens $250M cell therapy 'launch facility' in Berkeley
Fierce Pharma
Bayer
cell therapy
Berkeley
Californi
BlueRock Therapeutics
Flag link:
Novo Nordisk Foundation to establish €127 million cell therapy plant
Novo Nordisk Foundation to establish €127 million cell therapy plant
Biopharma Reporter
Novo Nordisk
cell therapy
Denmark
Flag link:
Cell therapy developer closes funding round to support diabetes program
Cell therapy developer closes funding round to support diabetes program
BioPharma Dive
cell therapy
Seraxis
funding
Eli Lilly
Flag link:
Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe
Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe
Reuters
Oxford BioMedica
M&A
viral vectors
ABL Europe
cell therapy
Flag link:
FDA capacity forces delay to Iovance's cell therapy
FDA capacity forces delay to Iovance's cell therapy
Pharmaphorum
Iovance Biotherapeutics
lifileucel
cell therapy
FDA
melanoma
Flag link:
BioCardia’s Cell Therapy Unlikely to Meet Primary Endpoint in Phase III Heart Failure
BioCardia’s Cell Therapy Unlikely to Meet Primary Endpoint in Phase III Heart Failure
BioSpace
BioCardia
clinical trials
cell therapy
heart failure
CardiAMP
Flag link:
Mesoblast's CEO takes 30% pay cut to fund 3rd shot at cell therapy approval
Mesoblast's CEO takes 30% pay cut to fund 3rd shot at cell therapy approval
Fierce Biotech
Mesoblast
cell therapy
FDA
Pharma CEOs
executive compensation
Flag link:
Notch Therapeutics closes Vancouver lab, will focus on Toronto and Seattle offices
Notch Therapeutics closes Vancouver lab, will focus on Toronto and Seattle offices
Geekwire
Notch Therapeutics
Vancouver
Canada
cell therapy
Flag link:
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Bayer
cell therapy
Parkinson's Disease
clinical trials
Flag link:
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Bayer
Parkinson's Disease
cell therapy
bemdaneprocel
BlueRock Therapeutics
Flag link:
Aspen taps tech firms for digital Parkinson's trial
Aspen taps tech firms for digital Parkinson's trial
Pharmaphorum
Apen Neuroscience
Parkinson's Disease
cell therapy
Emerald Innovations
Rune Labs
Flag link:
BMS backs $255m round for contract cell maker Cellares
BMS backs $255m round for contract cell maker Cellares
Pharmaphorum
Cellares
funding
cell therapy
Bristol Myers Squibb
Flag link:
FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death
FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death
Fierce Biotech
Gilead Sciences
Arcellx
CAR-T
cell therapy
FDA
Flag link:
Thermo Fisher lays off 200-plus at clinical-stage cell and gene therapy factory in Florida
Thermo Fisher lays off 200-plus at clinical-stage cell and gene therapy factory in Florida
Fierce Pharma
ThermoFisher Scientific
layoffs
gene therapy
cell therapy
Flag link:

Pages